IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma

✍ Scribed by T. Kawaoka; H. Aikata; S. Takaki; A. Hiramatsu; K. Waki; N. Hiraga; D. Miki; M. Tsuge; M. Imamura; Y. Kawakami; S. Takahashi; H. Ochi; H. Tashiro; H. Ohdan; K. Chayama

• Book ID: 108886611
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 218 KB
• Volume: 18
• Category: Article
• ISSN: 1352-0504
• DOI: 10.1111/j.1365-2893.2011.01468.x